Ultralow Dose PET Imaging for PSMA Expression
Part of paid clinical trials in Englewood, New Jersey.
- Sponsor
- Akiva Mintz
- Study ID
- NCT06904313
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Healthy Volunteer
- Prostate CA
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 120 Years
- Healthy Volunteers
- Accepted
Interventions
- Piflufolastat F18 — DRUGParticipants will be injected with Piflufolastat F18 and imaged for up to 3 hours on a PET scanner
Study Details
The goal of this clinical trial is to evaluate an investigational ultralow dose PET imaging technique for prostate cancer detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold of the current clinical standard? Participants will be injected with a radioactive tracer called 18F-DCFPyL and be imaged on a new type of high sensitivity PET scanner for up to 3 hours
Key Dates
- Start date
- May 12, 2025
- Status verified
- Mar 2025
- Primary completion
- Jun 30, 2030
- Completion
- Jun 30, 2030
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Other: ultralow dose PSMA imaging groupHealthy subjects and cancer patients will be enrolled for an ultralow dose PET scan to evaluate image quality and optimize timing and reconstruction after reducing radiation doses 10-100 fold. Participants will be injected with a very small amount of radiotracer and imaged on a PET scanner for up to 3 hours
Primary Outcome Measure
Signal-to-Noise Ratio (SNR) [ Time Frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period. ]
Central Contacts
- Barbara Blanchfield9732554955
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Nuclear Imaging Institute | Englewood | New Jersey | 07631 |
Find similar trials in Englewood, NJ
By research site
Related Studies
- Ultralow Dose PET Imaging of 18F-FDG UptakePHASE2 · Recruiting · Akiva Mintz · Englewood, New Jersey
- Ultralow Dose PET Imaging for 18F-NaF UptakePHASE2 · Recruiting · Akiva Mintz · Englewood, New Jersey
- Ultralow Dose PET Imaging of 18F-flurpiridazPHASE2 · Enrolling By Invitation · Akiva Mintz · Englewood, New Jersey
- Studies of Blood Flow to the Brain During ThoughtRecruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland